BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2191233)

  • 1. Treatment of rapidly progressive glomerulonephritis due to Behçet's syndrome with intravenous cyclophosphamide.
    Tietjen DP; Moore WJ
    Nephron; 1990; 55(1):69-73. PubMed ID: 2191233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly-progressive glomerulonephritis in a patient with Behcet's disease: successful treatment with intravenous cyclophosphamide.
    Kim SD; Kim SH; Kim HR; Yoon CH; Lee SH; Park SH; Kim HY
    Rheumatol Int; 2005 Sep; 25(7):540-2. PubMed ID: 15986085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crescentic glomerulonephritis in Behçet's syndrome--results of therapy and review of the literature.
    Donnelly S; Jothy S; Barré P
    Clin Nephrol; 1989 Apr; 31(4):213-8. PubMed ID: 2714026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-stage renal failure due to crescentic glomerulonephritis in a patient with Behçet's syndrome. Review of the literature.
    Sakemi T; Yoshiyuki T; Ikeda Y; Suzuki N; Nagasawa K
    Am J Nephrol; 1998; 18(4):321-4. PubMed ID: 9653837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillary glomerulonephritis associated with Behçet's syndrome.
    Kim HJ; Kang SW; Park SJ; Kim TH; Kang MS; Kim YH
    Ren Fail; 2012; 34(5):637-9. PubMed ID: 22417126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive glomerulonephritis in Behçet's syndrome.
    Landwehr DM; Cooke CL; Rodriguez GE
    JAMA; 1980 Oct; 244(15):1709-11. PubMed ID: 6997523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
    Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
    Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone.
    Fort JG; Abruzzo JL
    Arthritis Rheum; 1988 Sep; 31(9):1194-8. PubMed ID: 3422017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
    Flynn JT; Smoyer WE; Bunchman TE; Kershaw DB; Sedman AB
    Am J Nephrol; 2001; 21(2):128-33. PubMed ID: 11359020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative glomerulonephritis with crescent formation in behcet's syndrome.
    Olsson PJ; Gaffney E; Alexander RW; Mars DR; Fuller TJ
    Arch Intern Med; 1980 May; 140(5):713-4. PubMed ID: 7396600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerulonephritis in Behçet's disease: report of seven cases and review of the literature.
    Altiparmak MR; Tanverdi M; Pamuk ON; Tunç R; Hamuryudan V
    Clin Rheumatol; 2002 Feb; 21(1):14-8. PubMed ID: 11954877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapidly progressive glomerulonephritis syndrome: course, pathomorphology and outcome (data of Kaunas University of Medicine Hospital 1996-2002)].
    Maslauskiene R; Urbanaviciene J
    Medicina (Kaunas); 2003; 39 Suppl 1():33-40. PubMed ID: 12761418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of "bolus" cyclophosphamide injections in Behçet's disease. Experience of 17 cases].
    Du LT; Fain O; Wechsler B; Cochereau I; Hoang PL; Souillem J; Piette JC; Blétry O; Godeau P
    Presse Med; 1990 Sep; 19(29):1355-8. PubMed ID: 2146608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal involvement in Behçet's disease. Case report and review of the literature.
    Yver L; Blanchier D; Aouragh F; Turpin Y; Chaubert N; Laregue M; Goujon JM; Touchard G
    Nephron; 1996; 73(4):689-91. PubMed ID: 8856272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
    Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
    Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal involvement in Behçet's disease. About six cases].
    Zahiri K; Hachim K; Zamd A; Fatihi E; Benghanem MG; Ramdani B; Sqalli S; Zaïd D
    Rev Med Interne; 2003 Jan; 24(1):4-10. PubMed ID: 12614852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.
    Friedman G; Granot H; Koplovic Y; Friedlander M
    Postgrad Med J; 1981 Jan; 57(663):54-6. PubMed ID: 7279827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's Disease and Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
    Oygar DD; Morris Y
    Intern Med; 2016; 55(16):2225-8. PubMed ID: 27522999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal involvement in Behçet's syndrome. Report of a case and a review of the literature.
    Bemelman FJ; Krediet RT; Schipper ME; Arisz L
    Neth J Med; 1989 Apr; 34(3-4):148-53. PubMed ID: 2657452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.